Venture Portfolio

If there’s one thing we share with entrepreneurs it’s our desire to change the world - for patients. This inspires us to look for game-changers and paradigm-shifts rather than incremental improvements. Browse our portfolio to see what we mean.

Use the filters above to refine results
Ghent, Belgium ABV IV
London, UK ABV 7 / ABV VI
Redwood City, California ABV II
Menlo Park, CA & Boston, MA ABV 8
Cambridge, UK ABV IV / ABV III
Palo Alto, California ABV IV
Case Study
Oslo, Norway ABV V
Cambridge, Massachusetts ABV III
Dublin, Ireland ABV V / AGE
Schlieren, CH ABV 8
Cary, North Carolina ABV II
Cambridge, England ABV III / ABV II
Durham, NC ABV 8
Waltham, MA, USA ABV VI / AGE
Case Study
Waltham, Massachusetts ABV V
London, UK ABV 7 / CCD1
Copenhagen, Denmark ABV III
Mountain View, California ABV IV
Case Study
New York and Jerusalem, Israel ABV V
Oxford, UK ABV III
Portsmouth, UK ABV II
Boulder, Colorado ABV V
Film
Basel, Switzerland and Cambridge, MA, USA ABV VI
Newark, CA ABV 8 / CCD2
Zurich, Switzerland ABV V
Ghent, Belgium ABV II
Watertown, Massachusetts ABV V
Chantilly, Virginia ABV IV
Waltham, Massachusetts ABV IV
San Diego, CA ABV VI
Menlo Park, California ABV II
Berlin, Germany ABV V / AGE / ABV II
Chicago, IL ABV 7
Boston, MA ABV 7
Paris, France ABV IV
Mechelen, Belgium ABV III
London, UK ABV VI
Film
Paris, France ABV VI
San Carlos, CA ABV 8
Burlingame, California ABV III
Redwood City, CA AGE / ABV IV
Elmwood Park, New Jersey ABV II
Nottingham, UK ABV IV
Boston, MA ABV 8
Cambridge, Massachusetts ABV V / ABV III
Mountain View, California ABV II
Boston, MA ABV VI
Boston, MA ABV 7
Boston, Massachusetts ABV VI
Boston, MA ABV VI
North Carolina, US ABV V / AGE
London, UK ABV III
San Diego, California ABV V
Redwood City, CA ABV 7
London, UK ABV VI
Minneapolis, Minnesota ABV V
Sunnyvale, California ABV III
Didcot, UK ABV V / AGE
Cambridge, UK ABV III / ABV II
Case Study
Billerica, Massachusetts ABV IV
San Diego, California ABV V / AGE
Case Study
Sophia Antipolis, France ABV VI
Munich, Germany ABV II
Boston, MA ABV 7
Basel, Switzerland ABV 7
Paris, France ABV IV
Edinburgh, UK ABV 7
Palo Alto, CA ABV 7
Abingdon, UK ABV II
South San Francisco, California ABV III
Case Study
Boston, MA ABV VI
Sunnyvale, California ABV V
Menlo Park, California ABV V
Boulder, Colorado ABV II
Menlo Park, CA ABV 7
Paris, France ABV IV
South San Francisco, California ABV IV
Oxford, UK ABV IV
Mansfield, Massachusetts ABV V
Case Study
Leiden, Netherlands ABV IV
Waltham, MA ABV VI
Mountain View, California ABV II
Cambridge, MA ABV 7
Hayward, California ABV II
San Diego, CA ABV 8
Cambridge, MA ABV 7
Germantown, Maryland ABV II
Film
Pleasanton, California ABV V / CCD1
Film
Case Study
Pleasanton, California ABV V / CCD1
Film
Pleasanton, California ABV V / CCD1
Pleasanton, California ABV VI / CCD1
Pleasanton, California ABV VI / CCD1
Pleasanton, California ABV VI / CCD1
Pleasanton, CA ABV 7 / CCD1
Pleasanton, CA ABV 7 / CCD1
Pleasanton, CA ABV 8 / CCD1
Case Study
Santa Barbara, CA ABV V / AGE
Vancouver, Canada ABV 7
Redwood City, CA ABV 7
Case Study
Cambridge, England ABV III / ABV II
San Mateo, California ABV V
San Francisco, CA ABV 7
San Francisco, CA ABV 7
Stanmore, UK ABV V
South San Francisco, California ABV II
Rockville, MD ABV IV
Basel, Switzerland & South San Francisco, California ABV IV
Abingdon, UK ABV IV
South San Francisco, CA ABV VI
San Francisco, CA ABV VI
Parsippany, New Jersey ABV V
Case Study
Foster City, CA ABV VI
Malvern, PA ABV VI
South San Francisco, CA ABV 8
Film
London, UK ABV VI
Film
Stockholm, Sweden ABV VI
St. Louis, MO & San Diego, CA ABV 8
Danderyd, Sweden ABV III
Alameda, California ABV III
San Diego, California ABV IV